BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 26370140)

  • 21. Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma.
    Mossad NA; Mahmoud EH; Osman EA; Mahmoud SH; Shousha HI
    Tumour Biol; 2014 Nov; 35(11):11559-64. PubMed ID: 25129443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.
    Leerapun A; Suravarapu SV; Bida JP; Clark RJ; Sanders EL; Mettler TA; Stadheim LM; Aderca I; Moser CD; Nagorney DM; LaRusso NF; de Groen PC; Menon KV; Lazaridis KN; Gores GJ; Charlton MR; Roberts RO; Therneau TM; Katzmann JA; Roberts LR
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):394-402; quiz 267. PubMed ID: 17368240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic Value of Glypican-3 for Hepatocellular Carcinomas.
    El-Saadany S; El-Demerdash T; Helmy A; Mayah WW; El-Sayed Hussein B; Hassanien M; Elmashad N; Fouad MA; Basha EA
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):811-817. PubMed ID: 29582639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic and prognostic role of serum glypican 3 in patients with hepatocellular carcinoma.
    Ozkan H; Erdal H; Koçak E; Tutkak H; Karaeren Z; Yakut M; Köklü S
    J Clin Lab Anal; 2011; 25(5):350-3. PubMed ID: 21919070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.
    Giannini EG; Marenco S; Borgonovo G; Savarino V; Farinati F; Del Poggio P; Rapaccini GL; Anna Di Nolfo M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
    Hepatology; 2012 Oct; 56(4):1371-9. PubMed ID: 22535689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of combined tests of serum golgi glycoprotein 73 and other biomarkers in diagnosis of small primary hepatocellular carcinoma.
    Zhao Y; Wang M; Cui C; Zhang L; Liao F; Li H; Wu X
    Cancer Biomark; 2015; 15(5):677-83. PubMed ID: 26406957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined detection of AFP-L3, GP73 and TIP30 enhances diagnostic accuracy for HBV-related cirrhosis and hepatocellular carcinoma.
    Yanming L; Yue C; Wencan C; Liangyin WU; Xijun L; Jiafeng Z; Fengping HE
    J Pak Med Assoc; 2019 Sep; 69(9):1279-1286. PubMed ID: 31511712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validity of alpha fetoprotein for diagnosis of hepatocellular carcinoma in cirrhosis.
    Sarwar S; Khan AA; Tarique S
    J Coll Physicians Surg Pak; 2014 Jan; 24(1):18-22. PubMed ID: 24411536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of diagnostic value of golgi protein GP73 and its genetic assay in primary hepatic carcinoma.
    Shi Y; Chen J; Li L; Sun Z; Zen L; Xu S; Zhang Y; Zhang L
    Technol Cancer Res Treat; 2011 Jun; 10(3):287-94. PubMed ID: 21517136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A preliminary study of serum marker alpha-enolase in the diagnosis of hepatocellular carcinoma].
    Luo X; Wei YQ; Hai L; Hu YC; Zhao ZJ; Ma WL; Ma LN; Liu XY; Ding XC
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):505-510. PubMed ID: 31357775
    [No Abstract]   [Full Text] [Related]  

  • 31. Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma.
    Sun Y; Zhu S; Wu Z; Huang Y; Liu C; Tang S; Wei L
    Oncotarget; 2017 Apr; 8(14):23427-23435. PubMed ID: 28178643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
    Wong RJ; Ahmed A; Gish RG
    Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma.
    Reichl P; Fang M; Starlinger P; Staufer K; Nenutil R; Muller P; Greplova K; Valik D; Dooley S; Brostjan C; Gruenberger T; Shen J; Man K; Trauner M; Yu J; Gao CF; Mikulits W
    Int J Cancer; 2015 Jul; 137(2):385-394. PubMed ID: 25529751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical relevance of serum endoglin level in Egyptian hepatocellular carcinoma patients.
    Elnemr DM; Abdel-Azeez HA; Labib HA; Abo-Taleb FM
    Clin Lab; 2012; 58(9-10):1023-8. PubMed ID: 23163119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the albumin-gamma-glutamyltransferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis.
    Pompili M; Addolorato G; Pignataro G; Rossi C; Zuppi C; Covino M; Grieco A; Gasbarrini G; Rapaccini GL
    J Gastroenterol Hepatol; 2003 Mar; 18(3):288-95. PubMed ID: 12603529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Search for Effective Serum Tumor Markers for Early Diagnosis of Hepatocellular Carcinoma Associated with Hepatitis C.
    Malov SI; Malov IV; Kuvshinov AG; Marche PN; Decaens T; Macek-Jilkova Z; Yushchuk ND
    Sovrem Tekhnologii Med; 2021; 13(1):27-33. PubMed ID: 34513063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical utility of plasma glypican-3 and osteopontin as biomarkers of hepatocellular carcinoma.
    Lee HJ; Yeon JE; Suh SJ; Lee SJ; Yoon EL; Kang K; Yoo YJ; Kim JH; Seo YS; Yim HJ; Byun KS
    Gut Liver; 2014 Mar; 8(2):177-85. PubMed ID: 24672660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
    Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and application of a fluorescence protein microarray for detecting serum alpha-fetoprotein in patients with hepatocellular carcinoma.
    Zhang A; Yin C; Wang Z; Zhang Y; Zhao Y; Li A; Sun H; Lin D; Li N
    J Int Med Res; 2016 Dec; 44(6):1414-1423. PubMed ID: 27885040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
    Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH
    Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.